Publication & Citation Trends
Most Cited Works
Publications
6 total
SIRPG expression positively associates with an inflamed tumor microenvironment and response to PD-1 blockade OA
Cited by 5
Semantic Scholar
Targeting focal adhesion kinase boosts immune response in KRAS/LKB1 co-mutated lung adenocarcinoma via remodeling the tumor microenvironment OA
Cited by 27
Semantic Scholar
Osimertinib in combination with anti-angiogenesis therapy presents a promising option for osimertinib-resistant non-small cell lung cancer OA
Cited by 22
Semantic Scholar
AYVM to AYMM transition on HER2 exon 20 insertion induces TKI resistance in NSCLC.
Cited by 3
Semantic Scholar
SLC40A1+ macrophages contribute to the immunosuppressive tumor microenvironment in EGFR-mutated lung cancer.
Cited by 5
Semantic Scholar
Pre-treatment plasma-informed circulating tumor DNA detection as an early identification of therapeutic benefit for patients with untreated advanced lung squamous cell carcinoma.
Cited by 0
Semantic Scholar
A first-in-human phase I, dose-escalation and dose-expansion study of SY-5007, a highly potent and selective RET inhibitor, in Chinese patients with advanced RET positive solid tumors.
Cited by 3
Semantic Scholar
Efficacy of immune checkpoint inhibitors in advanced non-small cell lung cancer harboring BRAF mutations OA
Cited by 14
Semantic Scholar
Research Topics
Lung Cancer Treatments and Mutations
(3)
Lung Cancer Diagnosis and Treatment
(2)
Lung Cancer Research Studies
(2)
Cancer Immunotherapy and Biomarkers
(1)
Sarcoma Diagnosis and Treatment
(1)
Frequent Co-Authors
Affiliations
Tongji University
National Medical Products Administration
Guangdong General Hospital
Wuxi No.2 People's Hospital
Shanghai Pulmonary Hospital